GenScript
GenScript Biotech is a privately held life science tools and services company founded in 2002, offering gene synthesis, peptide/protein services, CRISPR tools, mRNA, viral vectors, and cGMP peptide manufacturing to academic researchers and pharma/biotech customers worldwide.
- Company typePrivate
- Founded2002
- HeadquartersPiscataway, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What GenScript does
GenScript Biotech Corporation is a privately held life science research tools and services company founded in 2002 and headquartered in Piscataway, New Jersey, with a cGMP peptide manufacturing facility in Zhenjiang, China. The company provides an integrated portfolio spanning gene synthesis (FLASH Gene, GenBrick up to 200kb), custom peptide synthesis (PepPower, TurboTIDE), recombinant protein and antibody expression (TurboCHO), CRISPR gene editing tools (GenCRISPR, OmniGuide RNA), IVT mRNA and viral vector services (lentivirus, AAV), and clinical-grade cGMP peptide manufacturing for IND-enabling and commercial supply. Its proprietary platforms claim industry-leading turnaround times (5-day peptide synthesis, 5-day lentivirus packaging) and quality metrics (99.99% gene synthesis delivery rate, >98% peptide synthesis success).
The business serves primarily academic and research institutions (Yale, Harvard, Stanford, Columbia, Karolinska, Fred Hutchinson) along with pharmaceutical, biotechnology, cell-and-gene-therapy, and cosmetic-peptide customers through a hybrid direct-to-consumer e-commerce model on genscript.com (with localized CN/JP/EU/KR portals) and an enterprise direct-sales motion for cGMP and large-scale projects. Catalog products (antibodies, ELISA kits, recombinant proteins, precast gels, automated purification systems such as AmMag Quatro) ship next-day; custom and cGMP services are quote-based with multi-year contract options for clinical supply. The portfolio is anchored by ISO 9001:2015 certification, an ISO 27001-compliant information security stack, and a recently opened ICH Q7 / 21 CFR 210/211-compliant manufacturing facility that underwent an Rx-360 audit in March 2025. Bestzyme (enzyme products) and ProBio (CDMO) are operating subsidiaries extending vertical reach into adjacent reagent and contract manufacturing categories.
GenScript firmographics
Firmographics- Name
- GenScript
- Legal name
- GenScript Biotech Corporation
- Website
- https://genscript.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- GenScript Biotech is a privately held life science tools and services company founded in 2002, offering gene synthesis, peptide/protein services, CRISPR tools, mRNA, viral vectors, and cGMP peptide manufacturing to academic researchers and pharma/biotech customers worldwide.
- Ownership category
- akta.pro rank
GenScript industry classification
Industry- Product category
- Biological Research Reagents and Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream) (HLAAACAN)
Keywords
Where GenScript is headquartered
LocationHeadquarters
- HQ city
- Piscataway
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
GenScript business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Custom Peptide Synthesis Services: Research-grade and cGMP-grade custom peptide synthesis with regular and express delivery options. Quantities from mg to kg scale with >300 available modifications.
- Gene Synthesis Services: FLASH Gene synthesis and GenBrick large gene synthesis (up to 200kb) services for molecular biology research.
- Recombinant Protein/Antibody Expression: TurboCHO platform for protein and antibody expression in mammalian, bacterial, and insect systems. Includes bispecific antibody formats.
- CRISPR Gene Editing Products and Services: gRNA synthesis, Cas nucleases, HDR templates, CRISPR plasmids and libraries for genome editing applications.
- IVT mRNA and Viral Vector Services: mRNA synthesis including standard, saRNA, and circRNA formats with LNP formulation services. Lentivirus and AAV packaging services for gene therapy applications.
- Catalog Products: Off-the-shelf reagents including antibodies, ELISA kits, precast gels, recombinant proteins, cell lines, and instruments with next-day shipping.
- cGMP Peptide Manufacturing: Clinical-grade peptide API manufacturing for IND applications and clinical trials with regulatory affairs support for CMC filing.
- Catalog Peptides: 200+ in-stock peptides for diabetes research, neuroscience, cosmetics, and other applications with prices ranging from $38 to $15,600.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Catalog Peptides |
| Other | Pay-as-you-go | Custom Peptide Services |
| Other | Pay-as-you-go | Peptide Library Services |
| Other | Multi-year contract | cGMP Peptide Manufacturing |
| Other | Pay-as-you-go | AAV Packaging Service |
| Other | Pay-as-you-go | Lentivirus Packaging Service |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
GenScript product offering
Product offeringCore offering
GenScript is a life science company that provides custom biological synthesis and engineering services — including gene synthesis, peptide synthesis, recombinant protein and antibody expression, CRISPR gene editing tools, IVT mRNA synthesis, and viral vector (lentivirus/AAV) packaging — alongside a catalog of off-the-shelf reagents and a cGMP peptide manufacturing facility for clinical and commercial supply. The company serves academic, pharmaceutical, biotechnology, and cell/gene therapy customers worldwide through its e-commerce platform and dedicated enterprise sales channels.
Product overview
GenScript is a life science company offering a comprehensive portfolio of biological research products and services organized into major categories: Gene Services (FLASH Gene synthesis, GenBrick long fragment synthesis, cloning), Protein Services (TurboCHO expression kits and services, recombinant protein/antibody production across mammalian/bacterial/insect/cell-free systems), CRISPR Gene Editing (OmniGuide RNA, Cas proteins, gRNA design tools, cell lines), IVT mRNA Services (mRNA synthesis, saRNA, circRNA, LNP formulations), Peptide Services (TurboTIDE express synthesis, custom peptides, peptide libraries via PepPower/PepHTS platforms, cGMP manufacturing, neoantigen peptides, GLP-1 agonists), Oligo Synthesis, Reagent Antibodies, and Cell Engineering (lentivirus/AAV packaging, stable cell lines). The company also maintains a catalog of reagent products including automated purification systems (AmMag Quatro), precast gels, antibodies, and ELISA kits. Quality systems include ISO 9001 certification and TQM protocols.
Differentiator
Problem solved
Functional benefit
Brands
- Bestzyme: Enzyme products brand
- ProBio
- PepPower
- TurboCHO
- FLASH Gene
- GenCRISPR
- TurboTIDE
- OmniGuide RNA
- ArgonShield
- CellPower
- GenSmart
- GenSpark
- GenCircle
- GenBrick
- GenEZ
- CytoSinct
- SurePAGE
- eBlot
- eStain
- AmMag
- AccuPep
Products and services
- Gene Synthesis Services
- Custom Peptide Synthesis
- TurboTIDE Peptide Synthesis
- TurboCHO Antibody Expression Service
- Protein Expression Services
- CRISPR Gene Editing Services
- IVT mRNA Services
- Research Grade AAV Packaging
- Lentivirus Packaging Service
- Peptide Library Service
- Neoantigen Peptide Service
- cGMP Peptide Synthesis
- GLP-1 Receptor Agonist Peptide Service
- Cosmetic Peptide Synthesis
- Catalog Peptides
- Oligo Synthesis Services
- Reagent Antibody Services
- DNA Mutant Library Services
- Cell Engineering Services
- Catalog Life Science Reagent Products
- AI Drug Discovery Solutions
- AmMag Quatro Purification Systems
Quantifiable outcome
- 99.99% gene synthesis delivery rate
- +5 more outcomes
Companies that use GenScript
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles3 records
GenScript technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
GenScript partnerships and signals
Strategic signalScale indicators11 records
Recent moves6 records
Expansion highlights6 records
GenScript competitors and assessment
Company assessmentDirect peers
- Twist Bioscience: Direct competitor in gene synthesis, oligonucleotide synthesis, and DNA data storage, offering NGS-targeted and synthetic biology product lines that compete head-to-head with GenScript's FLASH Gene and oligo services.
- Integrated DNA Technologies (IDT): Division of Danaher; major direct peer in custom oligonucleotides, gene synthesis, and CRISPR reagents, with overlapping academic and biopharma customer base and a global manufacturing footprint.
- Eurofins Genomics: Operates a comparable portfolio of gene synthesis, DNA sequencing, and synthetic biology services, targeting the same European and US academic/biotech customers as GenScript.
- Bio-Techne: Competes directly in recombinant proteins, antibodies, ELISA kits, and cell/gene therapy reagents — overlapping substantially with GenScript's catalog products and protein services lines.
- Bachem: Leading peptide API CDMO specializing in cGMP peptide manufacturing for GLP-1 and rare disease programs — directly competes with GenScript's emerging cGMP peptide business for clinical and commercial contracts.
- PolyPeptide Group: Global peptide CDMO serving pharma and cosmetic peptide markets; competes with GenScript's custom peptide and cGMP peptide API offerings, particularly in GLP-1 and specialty therapeutic peptides.
- GenScript Biotech (HKEX: 1548): Hong Kong-listed parent/affiliate operating the Bestzyme and ProBio subsidiaries referenced in the data; functions as a sister entity competing across the same gene, peptide, protein, and CDMO service categories.
Broad incumbents
- Thermo Fisher Scientific: Dominant life sciences tools incumbent with GeneArt gene synthesis, Invitrogen protein/antibody expression, and a global CDMO network — provides broader-portfolio competition to GenScript's research services and emerging CDMO ambitions.
Emerging players
- ATUM (formerly DNA2.0): Specialized gene synthesis and protein engineering CRO focused on synthetic biology and antibody discovery; addresses an overlapping but narrower customer set than GenScript.
- Synbio Technologies: China-based gene synthesis and synthetic biology services competitor; competes with GenScript on price in research-grade gene and oligo services, particularly in Asia-Pacific.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
GenScript social profiles
Digital presenceGenScript compliance and trust
Trust signalCompliance2 records
GenScript financial estimates
Financial estimateRevenue estimate
Valuation estimate
GenScript leadership team
Management profileNumber of profiles
GenScript subsidiaries and ownership
Company hierarchySubsidiaries2 records
GenScript funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GenScript M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GenScript
What does GenScript do?
GenScript is a life science company that provides custom biological synthesis and engineering services — including gene synthesis, peptide synthesis, recombinant protein and antibody expression, CRISPR gene editing tools, IVT mRNA synthesis, and viral vector (lentivirus/AAV) packaging — alongside a catalog of off-the-shelf reagents and a cGMP peptide manufacturing facility for clinical and commercial supply. The company serves academic, pharmaceutical, biotechnology, and cell/gene therapy customers worldwide through its e-commerce platform and dedicated enterprise sales channels.
Is GenScript a public or private company?
GenScript is a private company. It is classified as unknown and is currently operating.
When was GenScript founded?
GenScript was founded in 2002. It employs 5,001 to 10,000 people.
Where is GenScript based?
GenScript is headquartered in Piscataway, United States, in the North America region.
How does GenScript make money?
Eight revenue lines are on record. Custom Peptide Synthesis Services are the primary driver. The others are gene Synthesis Services, recombinant Protein/Antibody Expression, CRISPR Gene Editing Products and Services, IVT mRNA and Viral Vector Services, catalog Products, cGMP Peptide Manufacturing and catalog Peptides.
Who are GenScript's main competitors?
Direct peers on record are Twist Bioscience, Integrated DNA Technologies (IDT), Eurofins Genomics, Bio-Techne, Bachem, PolyPeptide Group and GenScript Biotech (HKEX: 1548). Thermo Fisher Scientific is listed as a broad incumbent. Emerging players are ATUM (formerly DNA2.0) and Synbio Technologies.
Does GenScript have an API?
No public API is recorded for GenScript.
What industry is GenScript in?
GenScript's product category is Biological Research Reagents and Services. Its primary akta.pro industry code is HLAAACAN, Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream). Its NAICS code is 541714 and its SIC code is 2835.